Novo Nordisk reported DKK106.26B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Bausch Health Companies USD 2.19B 160M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Merck USD 11.78B 345M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Novo Nordisk DKK 106.26B 11.21B Mar/2026
Novo Nordisk DKK 14.27B 72.1B Jun/2025
Pacira USD 125.64M 1.57M Mar/2026
Sanofi EUR 482M 85M Mar/2026
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026